Revive Therapeutics Ltd. (TSX-V: R V V) (OTCQB: R V V T F)
  • Home
  • ABOUT
    • Management
    • Scientific Advisors
    • Board of Directors
  • R & D
    • Product Pipeline
    • Bioinformatics
    • ENDOCANNABINOIDS
    • Blockchain / AI
  • INVEST
  • NEWS
  • CONTACT

 Investor Relations

Stock Quote
TSX VENTURE: R V V  |  OTCQB: R V V T F  |  FSE: 31R.F
​
Corporate Presentation
February 28, 2018​​​

SEDAR Filings
Click here  (Forwards to SEDAR website)

Capital Structure
57,516,417 common shares (63,125,883 fully-diluted)
Warrants:
2,415,715 Warrants @$0.18 (expire June 18, 2018)
50,400 Finder’s Warrants @$0.10 (one common share and one-half warrant @$0.18)

Stock Options:
3,118,151 stock options
(925,000 @ $0.60; 590,000 @ $0.66; 38,151 @ $0.30; 965,000 @ $0.28; 250,000 @ $0.20; 350,000 @ $0.335)

Social Media


​Stock Exchanges

Picture
Picture
Picture

    Enter email
Subscribe to Press Releases

Privacy Policy

Disclaimer

© COPYRIGHT 2017.  Revive Therapeutics Ltd.   ALL RIGHTS RESERVED.
  • Home
  • ABOUT
    • Management
    • Scientific Advisors
    • Board of Directors
  • R & D
    • Product Pipeline
    • Bioinformatics
    • ENDOCANNABINOIDS
    • Blockchain / AI
  • INVEST
  • NEWS
  • CONTACT
✕